Maybe not the sort of product to promote on the Web. But would have expected some sort of chatter if the pharmacy trial produced a stand out outcome. So far have found nothing. Not even a mention on Exxe.it website. Time the company made a statement on the European activities. TGA approval would add weight to the sales argument but can not see it as a prerequisite. If TGA is that important for EU sales then the BOD do have a very big question to answer for their decision in the 1st quarter that Au market was too small. How about an update on the state of the distributors and their efforts to market?
ADO Price at posting:
19.5¢ Sentiment: Hold Disclosure: Held
